Phenotypic Screening Uncovered Anti-Myocardial Fibrosis Candidates Using a Novel 3D Myocardial Tissue Under Hypoxia
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1148983 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Myocardial fibrosis (MF) is a shared hallmark among cardiovascular diseases, reflecting a common thread in their pathogenesis. However, reliable MF models simulating the pathogenesis are limited, which leads to the urgent need for more efficient drugs targeting MF. Herein, a novel contractile three-dimensional (3D) myocardial tissue model integrating cardiomyocytes (CMs), cardiac-fibroblasts (CFs), and bone-marrow-derived macrophages (BMDMs) in collagen hydrogel was developed to simulate the clinical pathological changes of terminal stage of cardiovascular disease, heart failure, and screen compounds with anti-MF activity dependably. The 3D myocardial tissue model demonstrated precise, visualizable, and quantifiable contractile characteristics under hypoxia and drug interventions. 76 compounds extracted from the resins of T.vernicifluum, a traditional Chinese medicine with clear clinical benefits for fibrotic diseases, were screened for anti-fibrotic activity. Following the in vitro assay using 3D oxygen-glucose deprivation (OGD)-treated myocardial tissue model instead of two-dimensional (2D) transforming growth factor-β (TGF-β)-treated CFs model, two candidates including LQ-40 and SQ-3 exerts impressive anti-MF activity, which was further validated in left anterior descending coronary artery (LAD)-MF mouse model. The current results demonstrate the feasibility and advantage of the novel 3D contractile multicellular types model in the discovery of potential drugs for MF, and candidates with promising potential for MF.
2025-07-16 | GSE275028 | GEO
Project description:Phenotypic landscape of schizophrenia-associated genes defines candidates and their shared functions
| PRJNA475784 | ENA
Project description:Phenotypic screening is a valuable tool to both understand and engineer complex biological systems. We demonstrate the functionality of this approach in the development of cell-free protein synthesis (CFPS) technology. Phenotypic screening identified numerous compounds that enhanced protein production in yeast lysate CFPS reactions. Notably, many of these were competitive ATP kinase inhibitors, with exploitation of their inherent substrate promiscuity redirecting ATP flux towards heterologous protein expression. Chemoproteomic- guided strain engineering partially phenocopied drug effects, with a 30% increase in protein yield observed upon deletion of the ATP-consuming SSA1 component of the HSP70 chaperone. Moreover, drug-mediated metabolic rewiring coupled with template optimization generated the highest protein yields in yeast CFPS to date using a hitherto less efficient, but more cost-effective glucose energy regeneration system. Our approach highlights the utility of target-agnostic phenotypic screening and target identification to deconvolute cell-lysate complexity, adding to the expanding repertoire of strategies for improving CFPS.
2024-07-22 | PXD047986 | JPOST Repository
Project description:Screening of kavalactone reductase candidates in Nicotiana benthamiana
2018-12-22 | MSV000083277 | MassIVE
Project description:NGS for library QC and analysis of phenotypic screening
| PRJEB73744 | ENA
Project description:To unveil the role of Angiopoietin-2 in regulating vascular remodeling after myocardial infarction
2018-04-01 | GSE105223 | GEO
Project description:Acute colorectal obstruction has been reported to occur in 7 - 29% of all colorectal malignancies, but emergent surgical decompression is associated with high morbidity and mortality rates. Recently, self-expandable metal stents(SEMS) have been suggested as an alternative to surgery and effectively decompress the colonic obstruction and allow for bowel preparation and elective surgery. Theoretically, SEMSs are classified into uncovered stents and covered stents. Covered stents have the advantage of less frequent stent occlusion by tumor in-growth and the disadvantage of a high risk of stent migration, whereas uncovered stents are associated with less stent migration, although they appear to be more prone to tumor ingrowth. To overcome the drawbacks of conventional stents, a double-layered combination covered stent was developed. In the present study, the investigators evaluated the efficacy and safety of the newly designed covered stent by comparing it with the uncovered stent in patients with malignant colorectal obstruction.
| 2205076 | ecrin-mdr-crc
Project description:Prototype LNP-mRNA vaccine candidates [SC_RNAseq]
| PRJNA853803 | ENA
Project description:Myocardial regeneration capacity declines during the first week after birth and is linked to the adaptation to oxidative metabolism. Utilizing this regenerative window, we characterized the metabolic changes in myocardial injury in 1-day-old regeneration-competent and 7-day-old regeneration-compromised mice. The mice were either sham-operated or received left anterior descending coronary artery ligation, to induce myocardial infarction (MI) and acute ischemic heart failure. Myocardial tissue samples were collected after 21 days for metabolomics, transcriptomics and proteomics analyses. Phenotypic characterizations were carried out using echocardiography, histology as well as mitochondrial structural and functional measurements. By integrating the findings from metabolome and transcriptome examinations, we identified mitochondrial dysfunction at the level of the carnitine shuttle contributing to myocardial regeneration incompetence. Regeneration failure was linked to accumulation of acylcarnitines and insufficient metabolic capacity for fatty acid beta-oxidation. We further identified specific transcription factors and post-transcriptional regulation contributing to both regeneration competence and failure. Rather than shifting from the preferred myocardial oxidative fuel source, our results put forward the facilitation of mitochondrial fatty acid transport and improving the beta- oxidation pathway to overcome the metabolic barriers for repair and regeneration in adult mammals after MI and heart failure.
2022-02-04 | MSV000088783 | MassIVE
Project description:High-throughput phenotypic screens leveraging biochemical perturbations and high-content readouts are poised to advance therapeutic discovery, yet they remain constrained by limitations of scale. To address this, we establish a method of pooling exogenous perturbations followed by computational deconvolution to compress a screen’s required sample, labor, and financial input. We benchmark the approach with a bioactive small molecule library and a high-content imaging readout, demonstrating the feasibility and increased efficiency of compressed experimental designs compared to conventional approaches. To prove generalizability, we apply compressed screening in two different biological discovery campaigns. In the first, we use early-passage pancreatic cancer organoids to map transcriptional responses to alibrary oftumor-microenvironmentrecombinant protein ligands. We uncover reproducible phenotypic shifts induced by specific ligands that are distinct from canonical reference signatures and uniquely correlate with clinical outcome.In the second, we examine the modulatory effects of a known mechanism of action chemical compound library on primary human peripheral blood mononuclear cell immune responses. Through contrastive analyses, we identify molecules that potentiate and/or inhibit cell-type specific transcriptional features, uncover pleiotropic effects for individual compounds across diverse cell types, and realize a systems-level view of drug responses. In sum, our approach empowers phenotypic screens with information-rich readouts to advance drug discovery efforts as well as basic biological inquiry.
2024-05-13 | GSE267243 | GEO